Medicure Inc. (CVE:MPH – Get Free Report) hit a new 52-week high on Monday . The stock traded as high as C$1.26 and last traded at C$1.26, with a volume of 5400 shares changing hands. The stock had previously closed at C$1.18.
Medicure Trading Up 6.8%
The business’s 50 day simple moving average is C$0.96 and its 200-day simple moving average is C$0.87. The company has a debt-to-equity ratio of 4.65, a current ratio of 2.03 and a quick ratio of 1.29. The stock has a market capitalization of C$13.15 million, a P/E ratio of -6.46 and a beta of 0.90.
About Medicure
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Read More
- Five stocks we like better than Medicure
- What Are Some of the Best Large-Cap Stocks to Buy?
- D-Wave Goes International With South Korea Partnership
- ESG Stocks, What Investors Should Know
- Payment Giants Slide on Stablecoin Buzz—Is Now the Time to Buy?
- What Are the U.K. Market Holidays? How to Invest and Trade
- 5 Small Cap Stocks With Explosive Upside Potential
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
